Abstract
Invasive hemodynamic assessment remains the gold standard for the diagnosis of pediatric pulmonary hypertension and for longitudinal assessment of response to therapy. This analysis sought to describe the changes in hemodynamic variables after initiation of prostacyclin therapy and determine which changes bear predictive power of adverse clinical outcomes. A retrospective chart review of established patients at Cincinnati Children’s Hospital with pulmonary arterial hypertension (PAH) who required prostacyclin therapy between 2004 and 2018 was performed. The baseline hemodynamic parameters at diagnosis as well as change in those parameters between initial catheterization and post-prostacyclin initiation catheterization were independent variables. Cox proportional hazard regression and recursive partitioning analysis were used to characterize which hemodynamic factors predicted the composite adverse outcome (CAO) defined as death, lung transplantation, or reverse Pott’s shunt surgery. During the study period, 29 patients met inclusion criteria in which there were 7 CAOs: 4 deaths, 3 lung transplants, and 2 reverse Pott’s shunts. Median time between catheterizations was 86 days and between the initiation of prostacyclin therapy and the second catheterization was 54 days. Cox regression revealed that only baseline pulmonary artery pressure (> 51 mmHg) and a failure to increase cardiac index illustrated statistically significant hazard for occurrence of the CAO (p < 0.01). These criteria significantly dichotomized the population in a Kaplan–Meier analysis into likelihoods of experiencing the CAO. While controlling for other hemodynamic variables, the absence of augmentation of cardiac index after the initiation of prostacyclin therapy is a valuable prognostic indicator of adverse PAH outcomes in pediatrics.
Similar content being viewed by others
Availability of Data and Material
Available on request.
References
Berger RM et al (2012) Clinical features of paediatric pulmonary hypertension: a registry study (in eng). Lancet 379(9815):537–546. https://doi.org/10.1016/S0140-6736(11)61621-8
del Cerro Marín MJ et al (2014) Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry (in eng). Am J Respir Crit Care Med 190(12):1421–1429. https://doi.org/10.1164/rccm.201406-1052OC
Rosenzweig EB et al (2019) Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management (in eng). Eur Respir J. https://doi.org/10.1183/13993003.01916-2018
Abman SH et al (2015) Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society (in eng). Circulation 132(21):2037–2099. https://doi.org/10.1161/cir.0000000000000329
Hansmann G et al (2019) 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT (in eng). J Heart Lung Transplant 38(9):879–901. https://doi.org/10.1016/j.healun.2019.06.022
Sandoval J, Bauerle O, Gomez A, Palomar A, Martínez Guerra ML, Furuya ME (1995) Primary pulmonary hypertension in children: clinical characterization and survival (in eng). J Am Coll Cardiol 25(2):466–474. https://doi.org/10.1016/0735-1097(94)00391-3
Sitbon O et al (2002) Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival (in eng). J Am Coll Cardiol 40(4):780–788. https://doi.org/10.1016/s0735-1097(02)02012-0
D'Alonzo GE et al (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry (in eng). Ann Intern Med 115(5):343–349. https://doi.org/10.7326/0003-4819-115-5-343
Bobhate P et al (2015) Cardiac catheterization in children with pulmonary hypertensive vascular disease (in eng). Pediatr Cardiol 36(4):873–879. https://doi.org/10.1007/s00246-015-1100-1
Simonneau G et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension (in eng). Eur Respir J. https://doi.org/10.1183/13993003.01913-2018
Di Maria M et al (2019) Parameters of right ventricular function reveal ventricular-vascular mismatch as determined by right ventricular stroke work versus pulmonary vascular resistance in children with pulmonary hypertension. J Am Soc Echocardiogr. https://doi.org/10.1016/j.echo.2019.09.013
Ploegstra M-J, Douwes JM, Roofthooft MT, Zijlstra WM, Hillege HL, Berger RM (2014) Identification of treatment goals in paediatric pulmonary arterial hypertension. Eur Respir J 44(6):2014. https://doi.org/10.1183/09031936.00030414
Beghetti M (2014) Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Eur Respir J 44(6):2014. https://doi.org/10.1183/09031936.00164014
Di Maria MV et al (2014) RV stroke Work in children with pulmonary arterial hypertension: estimation based on invasive haemodynamic assessment and correlation with outcomes. Heart 100(17):2014. https://doi.org/10.1136/heartjnl-2013-305298
Taylor CJ, Derrick G, McEwan A, Haworth SG, Sury MR (2007) Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension (in eng). Br J Anaesth 98(5):657–661. https://doi.org/10.1093/bja/aem059
Hill KD, Lim DS, Everett AD, Ivy DD, Moore JD (2010) Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry (in eng). Catheter Cardiovasc Interv 76(6):865–873. https://doi.org/10.1002/ccd.22693
O'Byrne ML et al (2015) Predictors of catastrophic adverse outcomes in children with pulmonary hypertension undergoing cardiac catheterization: a multi-institutional analysis from the pediatric health information systems database (in eng). J Am Coll Cardiol 66(11):1261–1269. https://doi.org/10.1016/j.jacc.2015.07.032
Beghetti M et al (2016) Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension) (in eng). Int J Cardiol 203:325–330. https://doi.org/10.1016/j.ijcard.2015.10.087
Wiegand G, Kerst G, Baden W, Hofbeck M (2010) Noninvasive cardiac output determination for children by the inert gas-rebreathing method (in eng). Pediatr Cardiol 31(8):1214–1218. https://doi.org/10.1007/s00246-010-9806-6
Sheth SS, Maxey DM, Drain AE, Feinstein JA (2013) Validation of the Innocor device for noninvasive measurement of oxygen consumption in children and adults (in eng). Pediatr Cardiol 34(4):847–852. https://doi.org/10.1007/s00246-012-0555-6
Schäfer M et al (2018) Measuring flow hemodynamic indices and oxygen consumption in children with pulmonary hypertension: a comparison of catheterization and phase-contrast MRI. Pediatr Cardiol 39(2):268–274. https://doi.org/10.1007/s00246-017-1751-1
Funding
Not applicable.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Evers, P.D., Critser, P.J., Cash, M. et al. Prognostic Value of Change in Cardiac Index After Prostacyclin Initiation in Pediatric Pulmonary Hypertension. Pediatr Cardiol 42, 116–122 (2021). https://doi.org/10.1007/s00246-020-02460-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-020-02460-6